Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-11-179045
Filing Date
2011-06-30
Accepted
2011-06-30 16:57:41
Documents
4
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 331453
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 6922
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 6995
4 CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4331
  Complete submission text file 0001193125-11-179045.txt   350727
Mailing Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404
Business Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404 650-358-3300
NeurogesX Inc (Filer) CIK: 0001385830 (see all company filings)

EIN.: 943307935 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33438 | Film No.: 11942733
SIC: 2834 Pharmaceutical Preparations